EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inhibiting Amikacin Resistance in Multidrug-Resistant Bacteria with Cadmium and Pyrithione

Angel J Magaña, David Ngo, Kenneth Burgos, Carolina Dominguez Maldonado, Omniya Abdelmaksoud, Jan Sklenicka, Tung Tran, Fernando Pasteran, Verónica Jimenez, María S Ramirez, Marcelo E Tolmasky

Current Microbiology · 2025-09 · 82 (9)

DOI: 10.1007/s00284-025-04372-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Microbiology, online erschienen am 16.07.2025. Verfasst von Angel J Magaña und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University …. Hauptthemen laut MEDLINE: Amikacin, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Cadmium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ongoing antibiotic resistance crisis is one of the most pressing public health challenges. Multidrug-resistant bacterial pathogens are reaching the point where some are becoming untreatable. Consequently, besides discovering novel antibiotics, alternative strategies must be explored to manage the problem. One approach is developing inhibitors that overcome resistance to antibiotics currently in use. Resistance to aminoglycosides such as amikacin is mainly due to aminoglycoside-modifying enzymes. Despite being refractory to most resistance enzymes, the semisynthetic amikacin is inactivated by aminoglycoside 6′- N -acetyltransferases type I [AAC(6′)-I], of which AAC(6′)-Ib is the most common in Gram-negative pathogens. The discovery that certain divalent and monovalent cations interfere with enzymatic acetylation catalyzed by AAC(6′)-Ib opens possibilities for developing formulations combining antibiotics with these cations to enhance efficacy. Addition of CdCl₂ to in vitro enzymatic assays inhibited transfer of an acetyl group to the 6′- N position of amikacin, kanamycin, and tobramycin. Hence, Cd 2 ⁺ is a potential adjuvant to aminoglycosides for treating AAC(6′)-Ib-mediated resistant infections. It was initially disappointing that, as with other divalent cations, CdCl₂ addition to cultures of bacteria harboring AAC(6′)-Ib did not reverse resistance. However, the inhibitory action of Cd 2 ⁺ became evident when combined with the ionophore pyrithione. The complex efficiently inhibited resistance in Acinetobacter baumann ii and Klebsiella pneumoniae harboring AAC(6′)-Ib. Furthermore, the combination inhibited amikacin resistance in carbapenem-resistant K. pneumoniae clinical isolates. These results add another cation to the arsenal of potential aminoglycoside adjuvants, which could be developed alone or in coordination complexes with ionophores to treat multidrug-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmikacinDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsCadmiumPyridinesThionesBacteriaAcetyltransferasesMicrobial Sensitivity TestsHumans

Substanzen

AmikacinAnti-Bacterial AgentsCadmiumPyridinespyrithioneAcetyltransferasesThionesaminoglycoside N(6')-acetyltransferase

Autor:innen und Institutionen

  • Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, 92831, USA.
  • Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbran), Buenos Aires, Argentina.
  • Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, 92831, USA. mtolmasky@fullerton.edu.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIMHD NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Magaña, A. J., Ngo, D., Burgos, K., Dominguez Maldonado, C., Abdelmaksoud, O., Sklenicka, J., Tran, T., Pasteran, F., Jimenez, V., Ramirez, M. S., & Tolmasky, M. E. (2025). Inhibiting Amikacin Resistance in Multidrug-Resistant Bacteria with Cadmium and Pyrithione. Current Microbiology, 82(9). https://doi.org/10.1007/s00284-025-04372-1

Vancouver

Magaña AJ, Ngo D, Burgos K, Dominguez Maldonado C, Abdelmaksoud O, Sklenicka J, et al. Inhibiting Amikacin Resistance in Multidrug-Resistant Bacteria with Cadmium and Pyrithione. Current Microbiology. 2025;82(9). doi:10.1007/s00284-025-04372-1

BibTeX
@article{Magaa2025,
  author = {Magaña, Angel J and Ngo, David and Burgos, Kenneth and Dominguez Maldonado, Carolina and Abdelmaksoud, Omniya and Sklenicka, Jan and Tran, Tung and Pasteran, Fernando and Jimenez, Verónica and Ramirez, María S and Tolmasky, Marcelo E},
  title = {Inhibiting Amikacin Resistance in Multidrug-Resistant Bacteria with Cadmium and Pyrithione},
  journal = {Current Microbiology},
  year = {2025},
  volume = {82},
  number = {9},
  doi = {10.1007/s00284-025-04372-1}
}
Kostenlos starten →